‘Finding The Right Balance': Kate Middleton Pulls Out Of Key Royal Event Amid Cancer Recovery
Last Updated:
According to Britain's Press Association, the Princess of Wales is working to 'find the right balance' as she resumes public life following her treatment.
Kate Middleton, the Princess of Wales, pulled out of attending Royal Ascot, a major fixture in the British royal calendar, as she continues her recovery from cancer, Kensington Palace said.
The high-profile racing event, held in Berkshire, is known for its deep royal ties and social significance. While Prince William, King Charles III and Queen Camilla are expected to attend, Kate Middleton will skip the outing to focus on her health. According to Britain's Press Association, the Princess of Wales is working to 'find the right balance" as she resumes public life following her treatment.
The five-day gathering features the Royal Procession, where members of the royal family arrive in horse-drawn carriages, followed by races viewed from the exclusive Royal Enclosure, known for its strict formal dress code.
In March 2024, Kate Middleton revealed she was undergoing preventative chemotherapy for an undisclosed cancer. She announced in January 2025 that she was in remission but continues to take a cautious approach to public engagements.
Kate Middleton has made a handful of public appearances in recent days, including King Charles III's birthday parade and a royal event at St George's Chapel. Her gradual return mirrors that of King Charles, who is also undergoing cancer treatment and recently resumed public duties.
First Published:
June 18, 2025, 22:51 IST
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
4 hours ago
- Hindustan Times
Delhi: Tony Blair meets Rekha Gupta to discuss governance, urban reforms
Chief minister Rekha Gupta met former British prime minister Tony Blair on Thursday at the Delhi Secretariat where the two discussed governance, urban development and education reforms, the chief minister's office (CMO) said in a statement. The two also discussed India-UK relations and global democratic challenges, officials added. Blair is the founder of the think tank Tony Blair Institute for Global Change (TBI). 'The chief minister held discussions with Blair on the ongoing transformational efforts in digital governance, education, healthcare, and environmental reforms in Delhi. The chief minister shared how the Delhi government is working under the vision of a 'Viksit Dilli' to modernise education, healthcare, women empowerment, and urban infrastructure with a citizen-centric approach,' the CMO said. Gupta described the meeting as a positive experience for her government. 'The meeting was a golden opportunity for Delhi, and TBI and the Delhi government will explore ways to transform Delhi into a model city. We held discussions on administrative reforms, the use of technology, and collaborative efforts for citizen welfare,' she added. Environment minister Manjinder Singh Sirsa also met Blair, and said that Gupta and Blair discussed various services being delivered through NGOs by Blair. 'The CM shared a booklet highlighting the government's achievements in just 100 days. Blair was surprised by the scale and speed of progress over the 100 days, remarking that other governments should take inspiration from how Indian state governments are performing,' he added. 'Blair also shared his experiences in governance during his tenure as British PM, the changes he brought and how five-six projects were highlighted. Blair expressed interest in Delhi's rapid roll out of health services and said he looks forward to seeing them on his next visit,' Sirsa said.
News18
5 hours ago
- News18
‘Finding The Right Balance': Kate Middleton Pulls Out Of Key Royal Event Amid Cancer Recovery
Last Updated: According to Britain's Press Association, the Princess of Wales is working to 'find the right balance' as she resumes public life following her treatment. Kate Middleton, the Princess of Wales, pulled out of attending Royal Ascot, a major fixture in the British royal calendar, as she continues her recovery from cancer, Kensington Palace said. The high-profile racing event, held in Berkshire, is known for its deep royal ties and social significance. While Prince William, King Charles III and Queen Camilla are expected to attend, Kate Middleton will skip the outing to focus on her health. According to Britain's Press Association, the Princess of Wales is working to 'find the right balance" as she resumes public life following her treatment. The five-day gathering features the Royal Procession, where members of the royal family arrive in horse-drawn carriages, followed by races viewed from the exclusive Royal Enclosure, known for its strict formal dress code. In March 2024, Kate Middleton revealed she was undergoing preventative chemotherapy for an undisclosed cancer. She announced in January 2025 that she was in remission but continues to take a cautious approach to public engagements. Kate Middleton has made a handful of public appearances in recent days, including King Charles III's birthday parade and a royal event at St George's Chapel. Her gradual return mirrors that of King Charles, who is also undergoing cancer treatment and recently resumed public duties. First Published: June 18, 2025, 22:51 IST
&w=3840&q=100)
First Post
12 hours ago
- First Post
How new blood test could reveal cancer long before symptoms appear
Scientists at Johns Hopkins University in the US have developed a new blood test that can detect signs of cancer up to three years before symptoms appear. When cancer is present, tumours release small fragments of genetic material into the bloodstream. Researchers found that these fragments can be identified in blood samples long before symptoms emerge. This could allow doctors to detect cancer much earlier than current screening methods, improving the chances of timely treatment read more This could let doctors find cancer much earlier than current screening methods. Pixabay/Representational Image Has a new way to detect cancer early been found? Scientists at Johns Hopkins University in the US have created a new blood test that can pick up signs of cancer up to three years before any symptoms appear. Why is this important? This could let doctors find cancer much earlier than current screening methods, giving people a better chance of getting treated in time. ALSO READ | British tourist dies after being 'scratched' by a pup in Morocco: How common are rabies deaths today? STORY CONTINUES BELOW THIS AD The study was published in Cancer Discovery and carried out by teams from different Johns Hopkins centres. It was partly supported by the US National Institutes of Health. So, what is this new test? And what did the researchers discover from the study? Let's take a look: What the researchers found The study showed that small traces of cancer can be found in a person's blood as early as three years before they are formally diagnosed. This raises the possibility that doctors could one day spot cancer much sooner, when it is easier to treat or even cure. When someone has cancer, tumours release tiny fragments of genetic material into the bloodstream. The researchers found that this material can be detected in blood samples well before any symptoms show up. The study was carried out by teams from different Johns Hopkins centres. Pixabay/Representational Image Dr Yuxuan Wang, one of the study's authors, said, 'We were surprised to find cancer signals in the blood so early. Finding cancer three years earlier gives us a chance to treat it before it spreads.' To conduct the research, scientists used plasma samples from a major Atherosclerosis Risk in Communities (ARIC) study, which looks at risk factors linked to heart attacks, strokes, heart failure and other heart-related conditions, according to a press release. They examined blood from 26 people who were diagnosed with cancer within six months of giving the sample, and compared it with samples from 26 people who were not diagnosed with cancer. STORY CONTINUES BELOW THIS AD Out of the 52 people, eight tested positive using a multi-cancer early detection (MCED) lab test and were later diagnosed with cancer within four months of their blood being drawn. Notably, MCED tests are an experimental method of screening that checks for signs of several types of cancer at the same time. According to the American Cancer Society, these tests can look for pieces of DNA, RNA or proteins from abnormal cells. In six of the eight cancer cases, the researchers went back to check earlier blood samples, taken more than three years before diagnosis. In four of those cases, cancer markers were already present. What do the results mean? Dr Bert Vogelstein, senior author and professor of oncology at Johns Hopkins, said, 'This study shows the promise of MCED tests in detecting cancers very early, and sets the benchmark sensitivities required for their success.' Dr Nickolas Papadopoulos, also a senior author and professor of oncology, added, 'Detecting cancers years before their clinical diagnosis could help provide management with a more favourable outcome. Of course, we need to determine the appropriate clinical follow-up after a positive test for such cancers.' At present, no MCED test has received full approval from the US Food and Drug Administration (FDA) for general use. However, some are available commercially under more flexible rules as Laboratory Developed Tests. STORY CONTINUES BELOW THIS AD MCED tests are an experimental method of screening that checks for signs of several types of cancer at the same time. Pixabay/Representational Image Experts say MCED tests are not meant to replace current screening methods but could become useful tools for detecting cancers earlier, particularly those like colon cancer, which are often diagnosed at later stages. Of the eight participants whose cancers were picked up by the MCED test months before diagnosis, five later died from the disease. According to The New York Post, excluding non-melanoma skin cancers, more than two million new cancer cases are expected in the US in 2025, with over 618,000 people projected to die from the illness. That means nearly 1,700 deaths every day.
